生理学报最新文献

筛选
英文 中文
[Research progress of the dopamine system in neurological diseases]. [多巴胺系统在神经系统疾病中的研究进展]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0025
Yu-Qi Niu, Jin-Jin Wang, Wen-Fei Cui, Peng Qin, Jian-Feng Gao
{"title":"[Research progress of the dopamine system in neurological diseases].","authors":"Yu-Qi Niu, Jin-Jin Wang, Wen-Fei Cui, Peng Qin, Jian-Feng Gao","doi":"10.13294/j.aps.2025.0025","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0025","url":null,"abstract":"<p><p>The etiology of nervous system diseases is complicated, posing significant harm to patients and often resulting in poor prognoses. In recent years, the role of dopaminergic system in nervous system diseases has attracted much attention, and its complex regulatory mechanism and therapeutic potential have been gradually revealed. This paper reviews the role of dopaminergic neurons, the neurotransmitter dopamine, dopamine receptors and dopamine transporters in neurological diseases (including Alzheimer's disease, Parkinson's disease and schizophrenia), with a view to further elucidating the disease mechanism and providing new insights and strategies for the treatment of neurological diseases.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"309-317"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[c-Met-targeted chimeric antigen receptor T cells inhibit human serous ovarian cancer cell SKOV-3 in vitro]. [c- met靶向嵌合抗原受体T细胞体外抑制人浆液性卵巢癌细胞SKOV-3]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0002
Na-Na DU, Yan-Jun Zhang, Yan-Qiu Li, Lu Zhang, Ran An, Xiang-Cheng Zhen, Jing-Ting Min, Zheng-Hong Li
{"title":"[c-Met-targeted chimeric antigen receptor T cells inhibit human serous ovarian cancer cell SKOV-3 <i>in vitro</i>].","authors":"Na-Na DU, Yan-Jun Zhang, Yan-Qiu Li, Lu Zhang, Ran An, Xiang-Cheng Zhen, Jing-Ting Min, Zheng-Hong Li","doi":"10.13294/j.aps.2025.0002","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0002","url":null,"abstract":"<p><p>The study aimed to construct the second and third generation chimeric antigen receptor T cells (CAR-T) targeting the c-mesenchymal-epithelial transition factor (c-Met) protein, and observe their killing effect on human serous ovarian cancer cell SKOV-3. The expression of <i>MET</i> gene in ovarian serous cystadenocarcinoma, the correlation between <i>MET</i> gene expression and the abundance of immune cell infiltration, and the effect of <i>MET</i> gene expression on the tissue function of ovarian serous cystadenocarcinoma were analyzed by bioinformatics. The expression of c-Met in ovarian cancer tissues and adjacent tissues was detected by immunohistochemical staining. The second and third generation c-Met CAR-T cells, namely c-Met CAR-T(2G/3G), were prepared by lentivirus infection, and the cell subsets and infection efficiency were detected by flow cytometry. Using CD19 CAR-T and activated T cells as control groups and A2780 cells with c-Met negative expression as Non target groups, the kill efficiency on SKOV-3 cells with c-Met positive expression, cytokine release and cell proliferation of c-Met CAR-T(2G/3G) were explored by lactate dehydrogenase (LDH) release, ELISA and CCK-8 respectively. The results showed that <i>MET</i> gene expression was significantly up-regulated in ovarian cancer tissues compared with normal tissues, which was consistent with the immunohistochemistry results. However, in all pathological stages, there was no obvious difference in <i>MET</i> expression and no correlation between <i>MET</i> gene expression and the race and age of ovarian cancer patients. The second generation and third generation c-Met CAR-T cells were successfully constructed. After lentivirus infection, the proportion of CD8<sup>+</sup> T cells in c-Met CAR-T(2G) was upregulated, while there was no significant change in the cell subsets of c-Met CAR-T(3G). The LDH release experiment showed that the kill efficiency of c-Met CAR-T(2G/3G) on SKOV-3 increased with the increase of effect-target ratio. When the effect-target ratio was 20:1, the kill efficiency of c-Met CAR-T(2G) reached (42.02 ± 5.17)% (<i>P</i> < 0.05), and the kill efficiency of c-Met CAR-T(3G) reached (51.40 ± 2.71)% (<i>P</i> < 0.05). ELISA results showed that c-Met CAR-T released more cytokine compared to CD19 CAR-T and activated T cells (<i>P</i> < 0.05). Moreover, the cytokine release of c-Met CAR-T(3G) was higher than c-Met CAR-T(2G) (<i>P</i> < 0.01). The CCK-8 results showed that after 48 h, the cell number of c-Met CAR-T(2G) was higher than that of c-Met CAR-T(3G) (<i>P</i> < 0.01). In conclusion, both the second and third generation c-Met CAR-T can target and kill c-Met-positive SKOV-3 cells, with no significant difference. c-Met CAR-T(2G) has stronger proliferative ability, and c-Met CAR-T(3G) releases more cytokines.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"241-254"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progress on the mechanism and application of hyperbaric oxygen therapy for neurodegenerative diseases]. 高压氧治疗神经退行性疾病的机制及应用进展
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0033
Fang-Fang Wang, Nan Wang, Heng-Rong Yuan, Ji Xu, Jun Ma, Xiao-Chen Bao, Yi-Qun Fang
{"title":"[Progress on the mechanism and application of hyperbaric oxygen therapy for neurodegenerative diseases].","authors":"Fang-Fang Wang, Nan Wang, Heng-Rong Yuan, Ji Xu, Jun Ma, Xiao-Chen Bao, Yi-Qun Fang","doi":"10.13294/j.aps.2025.0033","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0033","url":null,"abstract":"<p><p>In 2040, neurodegenerative diseases (NDD) will overtake cancer as the second leading cause of death after cardiovascular and cerebrovascular diseases. Therefore, the search for effective intervention measures has become the top priority to deal with this difficult burden. Hyperbaric oxygen therapy (HBOT) has been used for the past 50 years to treat conditions such as decompression sickness, carbon monoxide poisoning and radiation damage. In recent years, studies have confirmed that HBOT has good effects in improving cognitive impairment after brain injury and stroke, and alleviating neurodegeneration and dysfunction related to NDD. Here we reviewed the pathogenesis and treatment state of NDD, introduced the application of HBOT in animal models and clinical studies of NDD, and expounded the application potential of HBOT in the treatment of NDD from the perspective of mitochondrial function, neuroinflammation, neurogenesis and angiogenesis, oxidative stress, apoptosis, microcirculation and epigenetics.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"318-326"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Crosstalk and the progression of hepatocellular carcinoma]. [相声与肝细胞癌的进展]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0035
Lei-Rong Gu, Hui Zhang, Juan Chen, Sheng-Tao Cheng
{"title":"[Crosstalk and the progression of hepatocellular carcinoma].","authors":"Lei-Rong Gu, Hui Zhang, Juan Chen, Sheng-Tao Cheng","doi":"10.13294/j.aps.2025.0035","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0035","url":null,"abstract":"<p><p>Malignant proliferating liver cancer cells possess the ability to detect and respond to various body signals, thereby facilitating tumor growth, invasion, and metastasis. One crucial mechanism through which hepatocellular carcinoma (HCC) cells interpret these signals is crosstalk. Within liver cancer tissues, cancer cells engage in communication with hepatic stellate cells (HSCs), tumor-associated macrophages (TAMs), and immune cells. This interaction plays a pivotal role in regulating the proliferation, invasion, and metastasis of HCC cells. Crosstalk occurs in multiple ways, each characterized by distinct functions. Its molecular mechanisms primarily involve regulating immune cell functions through the expression of specific receptors, such as CD24 and CD47, modulating cell functions by secreting cytokines like transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF), and mediating cell growth and proliferation by activating pathways such as Wnt/β-catenin and Hedgehog. A comprehensive understanding of the mechanisms and interactions within crosstalk is essential for unraveling the pathogenesis of HCC. It also opens up new avenues for the development of innovative therapeutic strategies. This article reviews the relationship between crosstalk and the progression of HCC, offering insights and inspiration for future research.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"267-276"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The pleiotropic role of MEF2C in bone tissue development and metabolism]. [MEF2C在骨组织发育和代谢中的多效作用]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0024
Hao-Jie Xiao, Rui-Qi Huang, Sheng-Jie Lin, Jin-Yang Li, Xue-Jie Yi, Hai-Ning Gao
{"title":"[The pleiotropic role of MEF2C in bone tissue development and metabolism].","authors":"Hao-Jie Xiao, Rui-Qi Huang, Sheng-Jie Lin, Jin-Yang Li, Xue-Jie Yi, Hai-Ning Gao","doi":"10.13294/j.aps.2025.0024","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0024","url":null,"abstract":"<p><p>The development of bone in human body and the maintenance of bone mass in adulthood are regulated by a variety of biological factors. Myocyte enhancer factor 2C (MEF2C), as one of the many factors regulating bone tissue development and balance, has been shown to play a key role in bone development and metabolism. However, there is limited systematic analysis on the effects of MEF2C on bone tissue. This article reviews the role of MEF2C in bone development and metabolism. During bone development, MEF2C promotes the development of neural crest cells (NC) into craniofacial cartilage and directly promotes cartilage hypertrophy. In terms of bone metabolism, MEF2C exhibits a differentiated regulatory model across different types of osteocytes, demonstrating both promoting and other potential regulatory effects on bone formation, with its stimulating effect on osteoclasts being determined. In view of the complex roles of MEF2C in bone tissue, this paper also discusses its effects on some bone diseases, providing valuable insights for the physiological study of bone tissue and strategies for the prevention of bone diseases.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"374-384"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of immune response with intestinal flora and metabolic reprogramming in patients with non-small cell lung cancer. 非小细胞肺癌患者免疫反应与肠道菌群和代谢重编程的关系。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0031
Rui Guo, Zhe He, Fan Liu, Hui-Zhen Peng, Li-Wei Xing
{"title":"Relationship of immune response with intestinal flora and metabolic reprogramming in patients with non-small cell lung cancer.","authors":"Rui Guo, Zhe He, Fan Liu, Hui-Zhen Peng, Li-Wei Xing","doi":"10.13294/j.aps.2025.0031","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0031","url":null,"abstract":"<p><p>Numerous research conducted in recent years has revealed that gut microbial dysbiosis, such as modifications in composition and activity, might influence lung tissue homeostasis through specific pathways, thereby promoting susceptibility to lung diseases. The development and progression of lung cancer, as well as the effectiveness of immunotherapy are closely associated with gut flora and metabolites, which influence immunological and inflammatory responses. During abnormal proliferation, non-small cell lung cancer cells acquire more substances and energy by altering their own metabolic pathways. Glucose and amino acid metabolism reprogramming provide tumor cells with abundant ATP, carbon, and nitrogen sources, respectively, providing optimal conditions for tumor cell proliferation, invasion, and immune escape. This article reviews the relationship of immune response with gut flora and metabolic reprogramming in non-small cell lung cancer, and discusses the potential mechanisms by which gut flora and metabolic reprogramming affect the occurrence, development, and immunotherapy of non-small cell lung cancer, in order to provide new ideas for precision treatment of lung cancer patients.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"289-299"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The regulatory effect and mechanism of PGC-1α on mitochondrial function]. [PGC-1α对线粒体功能的调控作用及机制]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0036
Song-Hua Nan, Chao-Jie Peng, Ying-Lin Cui
{"title":"[The regulatory effect and mechanism of PGC-1α on mitochondrial function].","authors":"Song-Hua Nan, Chao-Jie Peng, Ying-Lin Cui","doi":"10.13294/j.aps.2025.0036","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0036","url":null,"abstract":"<p><p>Peroxisome proliferator-activated receptor γ coactivator 1 α (PGC-1α) is a core member of the PGC-1 family and serves as a transcriptional coactivator, playing a crucial regulatory role in various diseases. Mitochondria, the main site of cellular energy metabolism, are essential for maintaining cell growth and function. Their function is regulated by various transcription factors and coactivators. PGC-1α regulates the biogenesis, dynamics, energy metabolism, calcium homeostasis, and autophagy processes of mitochondria by interacting with multiple nuclear transcription factors, thereby exerting significant effects on mitochondrial function. This review explores the biological functions of PGC-1α and its regulatory effects and related mechanisms on mitochondria, providing important information for our in-depth understanding of the role of PGC-1α in cellular metabolism. The potential role of PGC-1α in metabolic diseases, cardiovascular diseases, and neurodegenerative diseases was also discussed, providing a theoretical basis for the development of new treatment strategies.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"300-308"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[CXCR3 counteracts cisplatin-induced muscle atrophy by regulating E3 ubiquitin ligases, myogenic factors, and fatty acid β-oxidation pathways]. [CXCR3通过调节E3泛素连接酶、成肌因子和脂肪酸β-氧化途径来对抗顺铂诱导的肌肉萎缩]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0032
Miao-Miao Xu, Xiao-Guang Liu, Li-Ming Lu, Zhao-Wei Li
{"title":"[CXCR3 counteracts cisplatin-induced muscle atrophy by regulating E3 ubiquitin ligases, myogenic factors, and fatty acid β-oxidation pathways].","authors":"Miao-Miao Xu, Xiao-Guang Liu, Li-Ming Lu, Zhao-Wei Li","doi":"10.13294/j.aps.2025.0032","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0032","url":null,"abstract":"<p><p>This study aims to explore the role and mechanism of CXC chemokine receptor 3 (CXCR3) in cisplatin-induced skeletal muscle atrophy. Wild-type mice were divided into two groups: cisplatin group and control group (treated by normal saline). The results showed that, compared to the control group, the expression levels of CXCR3 mRNA and protein were significantly up-regulated in the skeletal muscle of the cisplatin group, suggesting that CXCR3 may play an important role in the model of cisplatin-induced skeletal muscle atrophy. To further investigate its role and potential mechanisms, CXCR3 knockout mice and wild-type mice were treated with cisplatin to induce skeletal muscle atrophy. The results revealed that CXCR3 knockout not only failed to alleviate cisplatin-induced skeletal muscle atrophy, but also further reduced body weight, skeletal muscle mass, and muscle fiber cross-sectional area. Further analysis showed that, in the cisplatin-induced muscle atrophy model, CXCR3 knockout significantly up-regulated the expression levels of E3 ubiquitin ligases in skeletal muscle and down-regulated the expression levels of myogenic regulatory factors. To explore the molecular mechanism by which CXCR3 gene deletion exacerbated cisplatin-induced skeletal muscle atrophy, transcriptomic sequencing was performed on the atrophied skeletal muscles of wild-type and CXCR3 knockout mice. The results showed that, compared to wild-type mice, 14 genes were significantly up-regulated and 12 genes were significantly down-regulated in the skeletal muscle of CXCR3 knockout mice. Gene set enrichment analysis (GSEA) revealed a significant enrichment of genes related to fatty acid β-oxidation. Quantitative real-time PCR validation results were consistent with the transcriptomic sequencing results. These findings suggest that CXCR3 may counteract cisplatin-induced skeletal muscle atrophy by up-regulating E3 ubiquitin ligases, down-regulating myogenic regulatory factors, and enhancing the recruitment of fatty acid β-oxidation-related genes.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"255-266"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Therapeutic potential of ion channel modulation in Alzheimer's disease]. 离子通道调节在阿尔茨海默病中的治疗潜力。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2025.0029
Bing Huang, Cheng-Min Yang, Zhi-Cheng Lu, Li-Na Tang, Sheng-Long Mo, Chong-Dong Jian, Jing-Wei Shang
{"title":"[Therapeutic potential of ion channel modulation in Alzheimer's disease].","authors":"Bing Huang, Cheng-Min Yang, Zhi-Cheng Lu, Li-Na Tang, Sheng-Long Mo, Chong-Dong Jian, Jing-Wei Shang","doi":"10.13294/j.aps.2025.0029","DOIUrl":"https://doi.org/10.13294/j.aps.2025.0029","url":null,"abstract":"<p><p>Alzheimer's disease (AD), a prototypical neurodegenerative disorder, encompasses multifaceted pathological processes. As pivotal cellular structures within the central nervous system, ion channels play critical roles in regulating neuronal excitability, synaptic transmission, and neurotransmitter release. Extensive research has revealed significant alterations in the expression and function of ion channels in AD, implicating an important role of ion channels in the pathogenesis of abnormal Aβ deposition, neuroinflammation, oxidative stress, and disruptions in calcium homeostasis and neural network functionality. This review systematically summarizes the crucial roles and underlying mechanisms of ion channels in the onset and progression of AD, highlighting how these channel abnormalities contribute to AD pathophysiology. We also discuss the therapeutic potential of ion channel modulation in AD treatment, emphasizing the importance of addressing multifactorial nature and heterogeneity of AD. The development of multi-target drugs and precision therapies is proposed as a future direction of scientific research.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"327-344"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143957252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transcriptomic analysis of key genes involved in sex differences in intellectual development]. [智力发展中涉及性别差异的关键基因转录组学分析]。
生理学报 Pub Date : 2025-04-25 DOI: 10.13294/j.aps.2024.0079
Jia-Wei Zhang, Xiao-Li Zheng, Hai-Qian Zhou, Zhen Zhu, Wei Han, Dong-Min Yin
{"title":"[Transcriptomic analysis of key genes involved in sex differences in intellectual development].","authors":"Jia-Wei Zhang, Xiao-Li Zheng, Hai-Qian Zhou, Zhen Zhu, Wei Han, Dong-Min Yin","doi":"10.13294/j.aps.2024.0079","DOIUrl":"https://doi.org/10.13294/j.aps.2024.0079","url":null,"abstract":"<p><p>Intelligence encompasses various abilities, including logical reasoning, comprehension, self-awareness, learning, planning, creativity, and problem-solving. Extensive research and practical experience suggest that there are sex differences in intellectual development, with females typically maturing earlier than males. However, the key genes and molecular network mechanisms underlying these sex differences in intellectual development remain unclear. To date, Genome-Wide Association Studies (GWAS) have identified 507 genes that are significantly associated with intelligence. This study first analyzed RNA sequencing data from different stages of brain development (from BrainSpan), revealing that during the late embryonic stage, the average expression levels of intelligence-related genes are higher in males than in females, while the opposite is observed during puberty. This study further constructed interaction networks of intelligence-related genes with sex-differential expression in the brain, including the prenatal male network (HELP-M: intelligence genes with higher expression levels in prenatal males) and the pubertal female network (HELP-F: intelligence genes with higher expression levels in pubertal females). The findings indicate that the key genes in both networks are Ep300 and Ctnnb1. Specifically, Ep300 regulates the transcription of 53 genes in both HELP-M and HELP-F, while Ctnnb1 regulates the transcription of 45 genes. Ctnnb1 plays a more prominent role in HELP-M, while Ep300 is more crucial in HELP-F. Finally, this study conducted sequencing validation on rats at different developmental stages, and the results indicated that in the prefrontal cortex of female rats during adolescence, the expression levels of the intelligence genes in HELP-F, as well as key genes Ep300 and Ctnnb1, were higher than those in male rats. These genes were also involved in neurodevelopment-related biological processes. The findings reveal a sex-differentiated intelligence gene network and its key genes, which exhibit varying expression levels during the neurodevelopmental process.</p>","PeriodicalId":7134,"journal":{"name":"生理学报","volume":"77 2","pages":"211-221"},"PeriodicalIF":0.0,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143958124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信